Show simple item record

dc.contributor.authorFerreiro-Iglesias, Aida
dc.contributor.authorLesseur, Corina
dc.contributor.authorMcKay, James
dc.contributor.authorHung, Rayjean J
dc.contributor.authorHan, Younghun
dc.contributor.authorZong, Xuchen
dc.contributor.authorChristiani, David
dc.contributor.authorJohansson, Mattias
dc.contributor.authorXiao, Xiangjun
dc.contributor.authorLi, Yafang
dc.contributor.authorQian, David C
dc.contributor.authorJi, Xuemei
dc.contributor.authorLiu, Geoffrey
dc.contributor.authorCaporaso, Neil
dc.contributor.authorScelo, Ghislaine
dc.contributor.authorZaridze, David
dc.contributor.authorMukeriya, Anush
dc.contributor.authorKontic, Milica
dc.contributor.authorOgnjanovic, Simona
dc.contributor.authorLissowska, Jolanta
dc.contributor.authorSzołkowska, Małgorzata
dc.contributor.authorSwiatkowska, Beata
dc.contributor.authorJanout, Vladimir
dc.contributor.authorHolcatova, Ivana
dc.contributor.authorBolca, Ciprian
dc.contributor.authorSavic, Milan
dc.contributor.authorOgnjanovic, Miodrag
dc.contributor.authorBojesen, Stig Egil
dc.contributor.authorWu, Xifeng
dc.contributor.authorAlbanes, Demetrios
dc.contributor.authorAldrich, Melinda C
dc.contributor.authorTardon, Adonina
dc.contributor.authorFernandez-Somoano, Ana
dc.contributor.authorFernandez-Tardon, Guillermo
dc.contributor.authorLe Marchand, Loic
dc.contributor.authorRennert, Gadi
dc.contributor.authorChen, Chu
dc.contributor.authorDoherty, Jennifer
dc.contributor.authorGoodman, Gary
dc.contributor.authorBickeböller, Heike
dc.contributor.authorWichmann, H-Erich
dc.contributor.authorRisch, Angela
dc.contributor.authorRosenberger, Albert
dc.contributor.authorShen, Hongbing
dc.contributor.authorDai, Juncheng
dc.contributor.authorField, John K
dc.contributor.authorDavies, Michael
dc.contributor.authorWoll, Penella
dc.contributor.authorTeare, M Dawn
dc.contributor.authorKiemeney, Lambertus A
dc.contributor.authorvan der Heijden, Erik H F M
dc.contributor.authorYuan, Jian-Min
dc.contributor.authorHong, Yun-Chul
dc.contributor.authorHaugen, Aage
dc.contributor.authorZienolddiny, Shanbeh
dc.contributor.authorLam, Stephen
dc.contributor.authorTsao, Ming-Sound
dc.contributor.authorJohansson, Mikael
dc.contributor.authorGrankvist, Kjell
dc.contributor.authorSchabath, Matthew B
dc.contributor.authorAndrew, Angeline
dc.contributor.authorDuell, Eric
dc.contributor.authorMelander, Olle
dc.contributor.authorBrunnström, Hans
dc.contributor.authorLazarus, Philip
dc.contributor.authorArnold, Susanne
dc.contributor.authorSlone, Stacey
dc.contributor.authorByun, Jinyoung
dc.contributor.authorKamal, Ahsan
dc.contributor.authorZhu, Dakai
dc.contributor.authorLandi, Maria Teresa
dc.contributor.authorAmos, Christopher I
dc.contributor.authorBrennan, Paul
dc.date.accessioned2018-12-03T10:41:05Z
dc.date.available2018-12-03T10:41:05Z
dc.date.issued2018-09-25
dc.identifier.citationNat Commun 2018, 9 (1):3927en
dc.identifier.issn2041-1723
dc.identifier.pmid30254314
dc.identifier.doi10.1038/s41467-018-05890-2
dc.identifier.urihttp://hdl.handle.net/10146/618226
dc.description.abstractLung cancer has several genetic associations identified within the major histocompatibility complex (MHC); although the basis for these associations remains elusive. Here, we analyze MHC genetic variation among 26,044 lung cancer patients and 20,836 controls densely genotyped across the MHC, using the Illumina Illumina OncoArray or Illumina 660W SNP microarray. We impute sequence variation in classical HLA genes, fine-map MHC associations for lung cancer risk with major histologies and compare results between ethnicities. Independent and novel associations within HLA genes are identified in Europeans including amino acids in the HLA-B*0801 peptide binding groove and an independent HLA-DQB1*06 loci group. In Asians, associations are driven by two independent HLA allele sets that both increase risk in HLA-DQB1*0401 and HLA-DRB1*0701; the latter better represented by the amino acid Ala-104. These results implicate several HLA-tumor peptide interactions as the major MHC factor modulating lung cancer susceptibility.
dc.description.sponsorshipTransdisciplinary Research for Cancer in Lung (TRICL) research team of the International Lung Cancer Consortium (ILCCO) was supported by (U19-CA148127 and CA148127S1). The ILCCO data harmonization is supported by Cancer Care Ontario Research Chair of Population Studies to R. H. and Lunenfeld-Tanenbaum Research Institute, Sinai Health System. TRICL-ILCCO Oncoarray was supported by in-kind genotyping Centre for Inherited Disease Research (26820120008i-0-26800068-1). CAPUA study was supported by FIS-FEDER/Spain grant numbers FIS-01/310, FIS-PI03-0365, and FIS-07-BI060604, FICYT/Asturias grant numbers FICYT PB02-67 and FICYT IB09-133, and the University Institute of Oncology (IUOPA), of the University of Oviedo and the Ciber de Epidemiología y Salud Pública. CIBERESP, SPAIN. The work performed in the CARET study was supported by the The National Institute of Health/National Cancer Institute: UM1 CA167462 (PI: Goodman), National Institute of Health UO1‐CA6367307 (PIs Omen, Goodman); National Institute of Health R01 CA111703 (PI Chen), National Institute of Health 5R01 CA15198901A1(PI Doherty). Norway study was supported by Norwegian Cancer Society, Norwegian Research Council The NELCS study: Grant Number P20RR018787 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH). The Liverpool Lung project is supported by the Roy Castle Lung Cancer Foundation. The Harvard Lung Cancer Study was supported by the NIH (National Cancer Institute) grants CA092824, CA090578, CA074386. The Multiethnic Cohort Study was partially supported by NIH Grants CA164973, CA033619, CA63464 and CA148127. The work performed in MSH-PMH study was supported by The Canadian Cancer Society Research Institute (020214), Ontario Institute of Cancer and Cancer Care Ontario Chair Award to RJH and GL and the Alan Brown Chair and Lusi Wong Programs at the Princess Margaret Hospital Foundation. NJLCS work was funded by the State Key Program of National Natural Science of China (81230067), the National Key Basic Research Program Grant (2011CB503805), the Major Program of the National Natural Science Foundation of China (81390543). Tampa Lung Cancer Study (Tampa) was supported by National Institutes of Health: R01 DE013158, PO1 CA68384 and R01 ES025460. The Shanghai Cohort Study (SCS) was supported by National Institutes of Health R01 CA144034 (PI: Yuan) and UM1 CA182876 (PI: Yuan). The Singapore Chinese Health Study (SCHS) was supported by National Institutes of Health R01 CA144034 (PI: Yuan) and UM1 CA182876 (PI: Yuan). TCL work has been supported in part the James & Esther King Biomedical Research Program (09KN-15), National Institutes of Health Specialized Programs of Research Excellence (SPORE) Grant (P50 CA119997), and by a Cancer Center Support Grant (CCSG) at the H. Lee Moffitt Cancer Center and Research Institute, an NCI designated Comprehensive Cancer Center (grant number P30-CA76292). The Vanderbilt Lung Cancer Study – BioVU dataset used for the analyses described was obtained from Vanderbilt University Medical Center’s BioVU, which is supported by institutional funding, the 1S10RR025141-01 instrumentation award, and by the Vanderbilt CTSA grant UL1TR000445 from NCATS/NIH. Dr. Aldrich was supported by NIH/National Cancer Institute K07CA172294 (PI: Aldrich) and Dr. Bush was supported by NHGRI/NIH U01HG004798 (PI: Crawford). The L2 study. Lung cancer cases and controls were recruited through a multicentric case-control study coordinated by the International Agency for Research on Cancer in Russia, Poland, Serbia, Czech Republic, and Romania from 2005 to 2013. Cases were incident cancer patients collected from general hospitals. Controls were recruited from individuals visiting general hospitals and out-patient clinics for disorders unrelated to lung cancer and/or its associated risk factors, or from the general population. Information on lifestyle risk factors, medical and family history was collected from subjects by interview using a standard questionnaire. All study participants provided written informed consent. The current study included 1,133 lung cancer cases and 1,117 controls genotyped on the Oncoarray. The study in Lodz center was partially funded by Nofer Institute of Occupational Medicine, under task NIOM 10.13: Predictors of mortality from non-small cell lung cancer - field study.en
dc.language.isoenen
dc.relation.urlhttps://www.nature.com/articles/s41467-018-05890-2en
dc.rightsArchived with thanks to Nature communicationsen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectlung canceren
dc.titleFine mapping of MHC region in lung cancer highlights independent susceptibility loci by ethnicity.en
dc.typeArticleen
dc.contributor.departmentNofer Institute of Occupational Medicineen
dc.identifier.journalNature Communicationsen
refterms.dateFOA2018-12-17T18:11:13Z
html.description.abstractLung cancer has several genetic associations identified within the major histocompatibility complex (MHC); although the basis for these associations remains elusive. Here, we analyze MHC genetic variation among 26,044 lung cancer patients and 20,836 controls densely genotyped across the MHC, using the Illumina Illumina OncoArray or Illumina 660W SNP microarray. We impute sequence variation in classical HLA genes, fine-map MHC associations for lung cancer risk with major histologies and compare results between ethnicities. Independent and novel associations within HLA genes are identified in Europeans including amino acids in the HLA-B*0801 peptide binding groove and an independent HLA-DQB1*06 loci group. In Asians, associations are driven by two independent HLA allele sets that both increase risk in HLA-DQB1*0401 and HLA-DRB1*0701; the latter better represented by the amino acid Ala-104. These results implicate several HLA-tumor peptide interactions as the major MHC factor modulating lung cancer susceptibility.


Files in this item

Thumbnail
Name:
Fine mapping.pdf
Size:
1.962Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Archived with thanks to Nature communications
Except where otherwise noted, this item's license is described as Archived with thanks to Nature communications